GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Cash from Discontinued Operating Activities

Immunoclin (Immunoclin) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Immunoclin's Cash from Discontinued Operating Activities for the three months ended in Oct. 2014 was $0.00 Mil. It means Immunoclin received $0.00 Mil from discontinued investing activities. Immunoclin's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Oct. 2014 was $0.00 Mil.

Immunoclin Cash from Discontinued Operating Activities Historical Data

The historical data trend for Immunoclin's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Cash from Discontinued Operating Activities Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Cash from Discontinued Operating Activities
- - -

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Immunoclin Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunoclin Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Immunoclin's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Cash from Discontinued Operating Activities
Comparable Companies
BOM:506128 ASX:ATX OSTO:ANNX IMUN ASX:FIJ ASX:FTT ATRX TSXV:THRM WAR:BLR FNAM ASX:NC6 XCNQ:VP ENLV ASX:RAC VODG TSXV:MFS OSTO:A1M XSAT:CLINE B ASX:MEB XCNQ:LILY
Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Website
http://www.immunoclin.com
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines